Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
8.77
-0.45 (-4.88%)
At close: Sep 25, 2026, 4:00 PM EDT
8.99
+0.22 (2.51%)
Pre-market: Sep 28, 2026, 4:00 AM EDT

Q32 Bio Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2614142---
Market Cap Growth
1044.60%-2.51%----
Enterprise Value
1609-25---
Last Close Price
8.773.323.44---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
3.861.37----
PS Ratio
4.860.76----
PB Ratio
1.970.977.38---
P/TBV Ratio
2.470.977.38---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
2.980.16----
EV/EBITDA Ratio
7.340.51----
EV/EBIT Ratio
7.460.52----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.373.33-0.71-2.320.22
Debt / EBITDA Ratio
0.230.81----
Net Debt / Equity Ratio
-0.95-0.78-10.41-0.35-0.04-1.23
Net Debt / EBITDA Ratio
-4.63-1.910.90-0.53-0.020.74
Net Debt / FCF Ratio
5.090.980.87-1.35-0.060.82
Asset Turnover
0.590.70--0.14-
Quick Ratio
19.784.314.771.870.784.60
Current Ratio
20.304.854.972.040.814.71
Return on Equity (ROE)
72.14%125.06%---2884.70%-
Return on Assets (ROA)
14.74%13.71%-59.28%-55.42%-50.59%-
Return on Capital Employed (ROCE)
19.40%33.50%-87.10%-146.50%-1003.50%-131.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
12.94%73.00%-113.92%---
FCF Yield
-7.59%-82.11%-161.78%---
Buyback Yield / Dilution
-21.91%-27.51%-2666.77%95.03%-8.57%-
SEC Filings: 10-K · 10-Q